Targeted Precision Oncology: Insights into the PARP Inhibitors Market
PARP Inhibitors Market Overview and Therapeutic Importance Poly (ADP-ribose) polymerase (PARP) inhibitors have become a foundational tool in precision oncology, particularly for cancers with DNA repair deficiencies. By exploiting synthetic lethality in tumors with homologous recombination deficiency (HRD), especially those harboring BRCA1/2 mutations, these agents extend beyond initial...
0 Comments 0 Shares 602 Views 0 Reviews
Sponsored
Sponsored
Sponsored
Sponsored